secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2022-04-06T23:59:59+00:00
Accession:  0001493152-22-009272
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical appoints Rachel Vaknin as CFO, replacing David Ben Naim effective April 1, 2022
--------------------------------------------------------------------------------

- David Ben Naim resigned as CFO effective April 1, 2022; Rachel Vaknin appointed as successor.
- Vaknin joined as VP Finance in Jan 2022; previously CFO at Imagry and FP&A manager at Mellanox.
- Vaknin receives base salary NIS32,000/mo + NIS8,000 global comp, annual bonus up to 20% of salary, and options for 20,000 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/0001493152-22-009272-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-009272

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer